AstraZeneca PLC Ordinary Shares (AZN)

Total Non-Current Liabilities

$33.87B

Quarterly · Period ending: · USD

AZN logo

AZN Total Non-Current Liabilities

Latest reported$33.87B
AZN Quarterly Total Non-Current Liabilities ($1.61B → $33.87B)
High-resolution chart · PNG

AZN total non-current liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

AstraZeneca PLC Ordinary Shares Total Non-Current Liabilities — Quarterly (USD)
Period endingTotal Non-Current Liabilities (USD)
33,870,399,000
34,061,000,000
34,738,000,000
34,431,000,000
34,076,000,000
35,993,000,000
35,298,000,000
38,191,000,000
36,176,000,000
35,891,000,000
31,411,000,000
30,277,000,000
32,752,000,000
36,016,000,000
33,132,000,000
34,181,000,000
38,813,000,000
41,174,000,000
43,482,000,000
43,660,000,000
35,726,000,000
28,967,000,000
30,784,000,000
31,552,000,000
28,088,000,000
27,952,000,000
28,664,000,000
30,461,000,000
30,784,000,000
30,770,000,000
30,315,000,000
32,658,000,000
29,871,000,000
30,544,000,000
30,329,000,000
34,677,000,000
34,050,000,000
30,751,000,000
30,601,000,000
32,928,000,000
34,694,000,000
31,749,000,000
26,746,000,000
20,714,000,000
20,720,000,000
20,987,000,000
21,619,000,000
19,874,000,000
20,165,000,000
20,400,000,000
16,595,000,000
15,999,000,000
15,378,000,000
15,979,000,000
15,679,000,000
16,059,000,000
14,349,000,000
13,242,000,000
13,606,000,000
13,765,000,000
15,753,000,000
15,971,000,000
15,930,000,000
17,226,000,000
16,078,000,000
16,193,000,000
16,459,000,000
17,230,000,000
17,115,000,000
16,937,000,000
17,404,000,000
17,516,000,000
18,116,000,000
17,909,000,000
17,855,000,000
15,680,000,000
7,700,000,000
5,194,000,000
5,069,000,000
5,251,000,000
5,045,000,000
5,069,000,000
4,310,000,000
4,417,000,000
4,517,000,000
4,310,000,000
3,315,000,000
2,792,000,000
4,583,000,000
3,623,000,000
2,621,000,000
2,394,000,000
2,293,371,729
2,198,617,774
2,135,000,000
2,082,414,003
2,048,612,904
2,264,505,818
3,413,734,594
2,709,539,129
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.